ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,368.00
26.50 (1.98%)
03 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  26.50 1.98% 1,368.00 1,370.00 1,370.50 1,372.00 1,341.00 1,341.00 7,976,847 16:35:06
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1889 11.52 55.61B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,341.50p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,087,815 shares in issue. The market capitalisation of Gsk is £55.61 billion. Gsk has a price to earnings ratio (PE ratio) of 11.52.

Gsk Share Discussion Threads

Showing 30876 to 30900 of 34075 messages
Chat Pages: Latest  1243  1242  1241  1240  1239  1238  1237  1236  1235  1234  1233  1232  Older
DateSubjectAuthorDiscuss
16/8/2022
19:05
The plaintiff in the first Zantac case appears to have voluntarily dismissed the case without settlement according to news wires
daneswooddynamo
16/8/2022
12:51
You wouldn't need a penny for halfpenny's thoughts......we all get them for free.How lucky are we?
redbaron10
16/8/2022
11:35
So you are not worth even a penny!
abdullla
16/8/2022
11:32
just filter him..
lippy4
16/8/2022
11:29
Change the record pal
alibizzle
16/8/2022
11:07
GSK are a very high risk. Its only greed that keeps many holding onto GSK. Its therefore important that many are aware of the Risks and avoid the hype its a good investment at this time of many Cancer Claims. So dont fall into any traps as MM’s will sell before you do. Q. Do you feel lucky???
halfpenny
16/8/2022
10:45
Halfpenny I'm not sure what you have against GSK and the joy you are taking from seeing investors lose money , but please stop as you are t helping anyone and it's pretty pathetic tbf
alibizzle
16/8/2022
10:24
halfpenny16 Aug '22 - 11:19 - 30609 of 30609 (filtered)
tradermichael
16/8/2022
10:24
court case story has run out of steam.
People are vaguely beginning to think in terms of recovery back to 1500, 1700 and 2200

netcurtains
16/8/2022
10:19
GSK don't be fooled as plenty of falls in the pipeline as Claims increase. Too Risky at this level the risk reward is low. Lawyers are ramping up claimants and getting ready for their Xmas bonuses. I see this as a small Cat bounce or is it a Kitten Bounce with huge falls to come soon. 800 or less is very feasible at this Risky stage..
halfpenny
16/8/2022
09:22
fair play one and all. luck to you as well.
unastubbs
16/8/2022
09:05
I need £17 to break even but tbh happy to sit on a loss for 2-3 years and collect dividends if need be
alibizzle
16/8/2022
09:04
About 2200 for me.
Not sure.
Who cares?

Break even is not a thing,
I always say it is where you are now that counts, not the past - that is been and gone.

GSK appears to be going up.
And that is good!

netcurtains
16/8/2022
08:50
High £15's for me right now.
A few days of gains north of 20p and I may top up / average down. That would give me confidence that £14 is the low.

tuftymatt
16/8/2022
08:43
what's your break even btw?
unastubbs
16/8/2022
08:40
dont be late
netcurtains
16/8/2022
08:30
woke appointment. gwgb.
unastubbs
16/8/2022
08:11
Substitute Walmsley full stop.
tradermichael
16/8/2022
07:39
Good to see GSK bounce back today.
I am a bit worried about the Elliott position (among other things!!).
News in the FT today that Elliott has exited its $2.5en investment in SoftBank after losing faith that the CEO could turn it around.
The shares were acquired in 2020, Elliott are thought to have sold some in 2021 at a good profit and then unloaded the rest earlier this year as the share price fell back.
Substitute GSK for SoftBank and Walmsley for Maysayoshi Son and the story could be otherwise identical.

spyder
16/8/2022
07:13
From todays announcement:
"
Tony Wood, Chief Scientific Officer, GSK , said: "Affinivax's exciting pneumococcal vaccine candidates, the potentially disruptive MAPs technology and their fantastic scientific talent, further strengthen our pipeline of novel vaccines and presence in the Boston area".
"

netcurtains
16/8/2022
07:06
Let's start as we mean to go on 👍🏻
tuftymatt
16/8/2022
00:17
free stock charts from uk.advfn.com
buywell3
15/8/2022
21:06
No professional company would release confidential information. So looks like it is just fake
maxplus2
15/8/2022
21:03
It is written last year. Irrelevant
maxplus2
15/8/2022
20:13
What is clear is that GSK have a hell of a lot to offer. Expect that we are at a price that could make us vulnerable
hamid1970
Chat Pages: Latest  1243  1242  1241  1240  1239  1238  1237  1236  1235  1234  1233  1232  Older

Your Recent History

Delayed Upgrade Clock